Quarterly report [Sections 13 or 15(d)]

Revenues from Contracts and Significant Customers (Company's product revenue) (Details)

v3.26.3
Revenues from Contracts and Significant Customers (Company's product revenue) (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenues from Contracts and Significant Customers        
Revenue $ 18,925 $ 17,025 $ 52,685 $ 45,173
Other revenue 234 606 1,229 2,010
Net revenue 19,159 17,631 53,914 47,183
Emrosi        
Revenues from Contracts and Significant Customers        
Revenue 9,002 4,883 23,329 9,748
Qbrexza        
Revenues from Contracts and Significant Customers        
Revenue 5,590 7,361 15,732 19,470
Accutane        
Revenues from Contracts and Significant Customers        
Revenue 3,023 2,769 9,694 9,818
Foam franchise products (Amzeeq & Zilxi)        
Revenues from Contracts and Significant Customers        
Revenue 942 1,311 2,933 3,973
Eurax        
Revenues from Contracts and Significant Customers        
Revenue 105   225  
Other / legacy product revenue        
Revenues from Contracts and Significant Customers        
Revenue $ 263 $ 701 $ 772 $ 2,164